Procter & Gamble Health Limited (BOM: 500126)

Market Cap	89.47B
Revenue (ttm)	11.51B
Net Income (ttm)	2.01B
Shares Out	16.60M
EPS (ttm)	121.07
PE Ratio	44.52
Forward PE	n/a
Dividend	120.00 (2.27%)
Ex-Dividend Date	Nov 28, 2024

Volume	1,363
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	4,640.30 - 5,640.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2024

About Procter & Gamble Health

Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble ...

• Industry: Pharmaceutical Preparations
• Founded: 1967
• Employees: 1,407
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500126

Financial Performance

In 2024, Procter & Gamble Health's revenue was 11.51 billion, a decrease of -6.37% compared to the previous year's 12.30 billion. Earnings were 2.01 billion, a decrease of -12.42%.